Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
US Stock MarketDetailed Quotes
Estrella Immunopharma (ESLA)
- 1.210
- -0.050-3.97%
Close May 12 16:00 ET
- 1.210
- 0.0000.00%
Post 20:01 ET
51.62MMarket Cap-3.46P/E (TTM)
1.230High1.210Low8.87KVolume1.220Open1.260Prev Close10.90KTurnover0.05%Turnover RatioLossP/E (Static)42.67MShares3.15052wk High-4.98P/B21.81MFloat Cap0.78052wk Low--Dividend TTM18.02MShs Float33.000Historical High--Div Yield TTM1.60%Range %0.630Historical Low1.228Avg Price1Lot Size
Estrella Immunopharma (ESLA) Key Financial Indicators
ESLA Earnings per Share (EPS)
According to the latest financial report of Estrella Immunopharma, the latest earnings per share (TTM) for the company is -0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ESLA Free Cash Flow (FCF)
Interested in knowing about Estrella Immunopharma's free cash flow? The latest report shows it as -177.49K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ESLA Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Estrella Immunopharma shows that the company's current ratio is 0.12, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ESLA Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Estrella Immunopharma, the quick ratio is 0.12, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ESLA Return on Equity (ROE)
Want to learn more about the financial health of Estrella Immunopharma? The latest ROE figure is -61.89%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ESLA Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Estrella Immunopharma, the total asset return on investment (ROA) is -18.30%.
Currency: USD
Quarterly
Loading...
ESLA Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Estrella Immunopharma's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
ESLA Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Estrella Immunopharma, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm